Now accepting nominations for the FiercePharma Marketing Awards
Applications are due Friday, September 13th. Submit your nominations today.
The longtime leader of the National Institute for Health and Care Excellence will step down in March after 21 years on the job.
Health and Human Services, hoping to resurrect a rule that would force drug prices into TV ads, appealed a judge's decision that blocked it.
Uncover the challenges of developing influenza vaccines and new approaches that may eventually lead to a more universal solution.
Neopharma, which has been buying and building plants for several years, is buying a sterile injectables plant and assets in Japan from India’s Lupin.
Famed Denver Broncos quarterback John Elway is joining Endo’s “Facts on Hand” awareness campaign for Dupuytren's contracture.
About 230 hemophilia A patients in England have had access to Hemlibra, but now authorities signed off on funding for many more.
Kinase inhibitors to treat cancer have driven nearly $100 billion in deals since 2010, a trend that's likely to grow, SVB Leerink analysts predict.
AstraZeneca has had high hopes for its Imfinzi-tremelimumab pairing. But after a high-profile miss last year, the combo has struck out again.
In a warning letter, the FDA details how a Chinese OTC drugmaker handed over documents faked just for the agency's inspection—and admitted it.
Already knocked by the FDA four times this year, Dr. Reddy’s now has a fifth Form 483 to dwell on. This time it’s at a plant with a history of faults.
Pfizer is ponying up $500 million on top of $100 million already committed to a gene therapy manufacturing facility in North Carolina.